Browsing Tag
NASDAQ
286 posts
Is Actelis Networks, Inc. quietly building an end-to-end AI infrastructure stack with this bold stock deal? (NASDAQ: ASNS)
Actelis Networks enters AI data center networking via Exaware acquisition. Discover what this means for growth, competition, and investors.
A biotech firm steps into battlefield airspace as Polyrizon Ltd. eyes drone stake (Nasdaq: PLRZ)
Polyrizon Ltd. plans a strategic stake in Colugo Systems Ltd.’s defense drone business. Discover what this cross-sector move means for investors and industry outlook.
Can Core Scientific turn bank financing into an AI infrastructure advantage before rivals catch up? (NASDAQ: CORZ)
Core Scientific secures $1B financing to expand AI data center capacity. Read how this funding could reshape growth, competition, and investor outlook.
Can Linkers Industries buy growth fast enough to outrun the dilution it just unleashed? (NASDAQ: LNKS)
Linkers Industries Limited raises $16M to expand operations and acquisitions. Discover whether growth can outpace dilution and reshape its regional strategy.
Can Banzai International escape small-cap software limbo with its ConnectAndSell move? (NASDAQ: BNZI)
Find out how Banzai International’s ConnectAndSell deal could double revenue and test its AI software strategy in 2026. Read more.
X-energy files for Nasdaq IPO as Talen Energy partnership broadens its nuclear power case
X-energy has filed for a Nasdaq IPO as it expands SMR ambitions with Talen Energy. Read what the move means for nuclear power, PJM, and investors.
Verde Clean Fuels (VGAS) names new CEO and hires Roth Capital as strategic alternatives process begins
Verde Clean Fuels (VGAS) names CFO George Burdette as CEO and hires Roth Capital to explore a sale or merger. Read what this means for investors and the clean fuels sector.
What ParaZero Technologies Ltd.’s latest India demo could signal for its global counter-drone ambitions (NASDAQ: PRZO)
ParaZero Technologies Ltd. expands into India with BonV Aero. Find out how this counter-drone move could shape its global ambitions.
VERAXA Biotech clears final shareholder hurdle as Voyager Acquisition votes yes on $1.35bn oncology de-SPAC
Voyager Acquisition shareholders approve VERAXA Biotech combination. The cancer ADC and TCE platform heads to NASDAQ as VRXA. Read the full analysis.
Adobe (Nasdaq: ADBE) Q1 FY2026 earnings: Record revenue, AI monetisation accelerates and Shantanu Narayen announces CEO transition
Adobe beats Q1 FY2026 estimates with $6.40bn revenue and AI ARR tripling YoY, but CEO Shantanu Narayen plans to step down. Read our full analysis.